This is a StreetInsider.com Premium Only Page

SAGE Therapeutics (SAGE) –

Nov 30, 2023 04:05 PM Form 4 Sage Therapeutics, Inc. For: Nov 28 Filed by: JONAS JEFFREY M

Nov 30, 2023 04:05 PM Form 4 Sage Therapeutics, Inc. For: Nov 28 Filed by: IGUCHI KIMI

Nov 30, 2023 04:05 PM Form 4 Sage Therapeutics, Inc. For: Nov 28 Filed by: Cook Anne Marie

Nov 8, 2023 06:56 AM Sage Therapeutics (SAGE) PT Lowered to $21 at RBC Capital

Nov 8, 2023 06:54 AM Sage Therapeutics (SAGE) PT Lowered to $24 at Scotiabank

Nov 8, 2023 06:30 AM Sage Therapeutics to Present at Upcoming November Investor Conferences

Nov 7, 2023 07:42 AM SAGE Therapeutics (SAGE) Enters Sales Agreement with Cowen for Up to $250M Shares

Nov 7, 2023 07:39 AM Form 8-K Sage Therapeutics, Inc. For: Nov 07

Nov 7, 2023 07:30 AM Form 424B5 Sage Therapeutics, Inc.

Nov 7, 2023 07:01 AM Form 10-Q Sage Therapeutics, Inc. For: Sep 30

Nov 7, 2023 06:46 AM Form 8-K Sage Therapeutics, Inc. For: Nov 07

Nov 7, 2023 06:34 AM SAGE Therapeutics (SAGE) Misses Q3 EPS by 69c

Nov 7, 2023 06:30 AM Sage Therapeutics Announces Third Quarter 2023 Financial Results and Highlights Pipeline and Business Progress

Oct 24, 2023 06:30 AM Sage Therapeutics to Report Third Quarter 2023 Financial Results on Tuesday, November 7, 2023

Oct 18, 2023 06:30 AM SAGE Therapeutics (SAGE) Granted FDA Orphan Drug Designation for SAGE-718

Oct 18, 2023 06:30 AM Sage Therapeutics Announces U.S. Food and Drug Administration Granted SAGE-718 Orphan Drug Designation for the Treatment of Huntington’s Disease

Oct 16, 2023 06:00 AM Sage Therapeutics (SAGE) PT Raised to $25 at Goldman Sachs

Oct 13, 2023 06:02 AM Sage Therapeutics (SAGE) PT Raised to $25 at Goldman Sachs

Oct 6, 2023 08:37 AM Metals and Mining Virtual Investor Conference: Presentations Now Available for Online Viewing

Oct 2, 2023 08:35 AM Metals & Mining Virtual Investor Conference Agenda Announced for October 3rd- October 5th

Sep 8, 2023 07:52 AM Sage Therapeutics (SAGE) PT Lowered to $24 at BofA Securities

Sep 7, 2023 06:39 AM Sage Therapeutics (SAGE) PT Raised to $20 at Mizuho Securities

Sep 7, 2023 06:12 AM Sage Therapeutics (SAGE) PT Lowered to $22 at RBC Capital

Sep 6, 2023 06:30 AM Sage Therapeutics to Present at Upcoming September Investor Conferences

Sep 1, 2023 10:00 PM Bragar Eagel & Squire, P.C. Is Investigating DigitalOcean, and Sage and Encourages Investors to Contact the Firm

Sep 1, 2023 08:13 AM Sage Therapeutics (SAGE) PT Lowered to $24 at TD Cowen

Sep 1, 2023 06:51 AM Sage Therapeutics (SAGE) PT Raised to $27 at Scotiabank

Aug 31, 2023 08:11 AM Salesforce, Crowdstrike, Ciena rise premarket; Dollar General slumps

Aug 31, 2023 06:46 AM Form 8-K Sage Therapeutics, Inc. For: Aug 28

Aug 31, 2023 06:30 AM SAGE Therapeutics (SAGE) Implements Strategic Reorganization to Support Plans for ZURZUVAE Commercial Launch

Aug 31, 2023 06:30 AM Sage Therapeutics Implements Strategic Reorganization to Support Plans for ZURZUVAE™ Commercial Launch and Pipeline Advancement

Aug 27, 2023 09:00 PM Bragar Eagel & Squire, P.C. Is Investigating Blink, Lovesac, and Sage and Encourages Investors to Contact the Firm

Aug 11, 2023 08:51 AM Form 4 Sage Therapeutics, Inc. For: Aug 09 Filed by: Barrett Elizabeth

Aug 9, 2023 08:19 AM Sage Therapeutics (SAGE) PT Lowered to $20 at Morgan Stanley

Aug 8, 2023 04:16 PM Form 4 Sage Therapeutics, Inc. For: Aug 04 Filed by: Greene Barry E

Aug 8, 2023 09:16 AM Sage Therapeutics (SAGE) PT Lowered to $28 at TD Cowen

Aug 8, 2023 07:41 AM Goldman Sachs Downgrades Sage Therapeutics (SAGE) to Neutral, 'stepping to the sidelines as we await more clarity'

Aug 8, 2023 06:54 AM Needham & Company Downgrades Sage Therapeutics (SAGE) to Hold

Aug 8, 2023 06:42 AM Sage Therapeutics (SAGE) PT Lowered to $19 at Mizuho Securities

Aug 8, 2023 06:41 AM Sage Therapeutics (SAGE) PT Lowered to $27 at H.C. Wainwright

Aug 8, 2023 05:30 AM Canaccord Genuity Downgrades Sage Therapeutics (SAGE) to Hold

Aug 8, 2023 04:39 AM Sage Therapeutics (SAGE) PT Lowered to $20 at Truist Securities

Aug 7, 2023 04:56 PM Oppenheimer Reiterates Perform Rating on Sage Therapeutics (SAGE)

Aug 7, 2023 12:56 PM BofA Securities Downgrades Sage Therapeutics (SAGE) to Neutral

Aug 7, 2023 12:44 PM Sage tumbles to record low on clinical depression pill setback

Aug 7, 2023 10:12 AM Stifel Downgrades Sage Therapeutics (SAGE) to Hold, 'we think Biogen is unlikely to buy Sage outright '

Aug 7, 2023 07:49 AM Form S-8 Sage Therapeutics, Inc.

Aug 7, 2023 07:23 AM Wedbush Downgrades Sage Therapeutics (SAGE) to Neutral

Aug 7, 2023 07:21 AM Form 10-Q Sage Therapeutics, Inc. For: Jun 30

Aug 7, 2023 07:12 AM SAGE Therapeutics (SAGE) sinks nearly 50% as trading resumes following CRL